Walleye Trading
GEN

Walleye Trading’s Genesis Healthcare, Inc. GEN Stock Holding History

Walleye Trading’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-500
Closed -$3K – 5703
2015
Q2 		$3K Buy
+500
New +$3.37K ﹤0.01% 4640

Other funds holding GEN

CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Walleye Trading's GEN Position: Q3 2018 in Review

Walleye Trading sold out of Genesis Healthcare, Inc. (GEN) in Q3 2018, closing a stake of 43,000 shares — an estimated $98K sold.

Walleye Trading first reported a position in GEN in Q3 2016 and held it in 3 quarters. The position peaked at $98K in Q2 2018. 77 funds tracked by Wall St. Rank hold GEN as of Q3 2018.

  • Walleye Trading reported no remaining Genesis Healthcare, Inc. position as of Q3 2018 after selling out during the quarter.
  • Walleye Trading sold 43,000 Genesis Healthcare, Inc. shares in Q3 2018, an estimated $98K.
  • Walleye Trading first reported a position in Genesis Healthcare, Inc. in Q3 2016 and held it in 3 quarters.
  • Walleye Trading's Genesis Healthcare, Inc. position peaked at $98K in Q2 2018.
  • 77 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q3 2018.

Based on Walleye Trading's 13F filing for Q3 2018, filed 14 Nov 2018.